6-gingerol attenuates renal interstitial fibrosis by downregulating PI3K/Akt/mTOR signaling pathway in unilateral ureteral obstruction rats Authors: Vivian Soetikno, Nouman Ahmad, Maritza Gantari Makhrus, Farah Fauzika Haikal, Muhammad Ali Rashidin, Abdullah Ahmad Shiddiq, Iskandar Budianto, Vetriselvan Subramaniyan Published: 2026 ABSTRACT AbstractRenal interstitial fibrosis is the predominant cause of end-stage renal disease. Oxidative stress and an increased PI3K/Akt/mTOR pathway play a key role in the development of renal interstitial fibrosis caused by ureteral obstruction. 6-gingerol (6-G) is known to have a natural antioxidant effect; however, the effect of 6-G on progressive renal fibrosis due to ureteral obstruction has not been fully elucidated. The aim of the study is to evaluate the antifibrotic effect of 6-G and characterize the underlying mechanism of its action on unilateral ureteral obstruction (UUO) rats. Male Sprague-Dawley rats underwent UUO via double ligation of the left ureter for a duration of 14 days. Sham rats underwent identical treatment, with the exception of the absence of double ligation. The levels of phosphorylated PI3K/Akt/mTOR in the kidney were assessed by semiquantitative immunoblotting, while the gene expressions of TGF-β1 and α-SMA were evaluated through qRT-PCR. Oxidative stress parameters were evaluated with an ELISA kit and spectrophotometer, while histopathological assessment was conducted through Masson’s trichrome, hematoxylin and eosin (HE), and immunohistochemical analysis of collagen type III. In comparison to UUO rats, renal fibrosis and collagen type III deposition were diminished, and the phosphorylation of PI3K/Akt/mTOR was reduced in rats treated with 6-G. 6-G also reduced the expression of TGF-β1 and α-SMA genes in obstructed kidneys. In comparison to UUO rats, rats administered with 6-G exhibited elevated activities of glutathione peroxidase and decreased levels of malondialdehyde. The findings suggest that 6-G is a potential therapeutic agent for renal interstitial fibrosis, with its antifibrotic actions perhaps facilitated by the enhanced activity of the PI3K/Akt/mTOR pathways and decreased oxidative stress in UUO rats.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1038/s41598-026-58386-1.Keywords: Renal injury, Gingerol, Oxidative damage, Fibrosis, Tubular atrophySubject terms: Diseases, Medical research, Molecular biology, Nephrology Introduction Obstructive nephropathy is a frequent urological condition characterized by defective urinary system structure and function, inadequate urine drainage, and hydronephrosis, leading to the deterioration of normal kidney structure and function, culminating in renal interstitial fibrosis, as well as a loss in renal function1. Renal interstitial fibrosis is the prevalent clinical characteristic and ultimate manifestation of chronic kidney disease (CKD), exhibiting morphological features such as glomerulosclerosis, tubular atrophy, chronic interstitial inflammation, fibrogenesis, and vascular rarefaction2. Despite considerable progress in understanding the process of renal fibrosis, the application of antifibrotic strategies in effective therapeutic therapy remains constrained3. Unilateral ureteral obstruction (UUO) is a widely used experimental model for studying renal interstitial fibrosis and obstructive nephropathy. This model is characterized by a series of pathophysiological alterations, including fibroblast proliferation and activation, inflammation, oxidative stress, epithelial-mesenchymal transition (EMT), and excessive extracellular matrix (ECM) deposition4. Among these mechanisms, oxidative stress plays a pivotal role from the early stages of kidney injury. UUO induces a significant increase in reactive oxygen species (ROS), lipid peroxidation markers such as malondialdehyde, superoxide anion production, and the expression of NADP(H) oxidase subunits5. Oxidative stress is intimately linked to the activation of intracellular signaling pathways, particularly the phosphoinositide-3-kinase (PI3K)/Akt/mTOR pathway. Evidence indicated a bidirectional relationship between oxidative stress and this signaling cascade, wherein oxidative stress can activate Akt through PI3K, hence enhancing cellular stress responses6–8. The activation of the PI3K/Akt/mTOR signaling pathway enhances the expression of profibrotic and epithelial-mesenchymal transition (EMT)-related genes, such as ⍺-SMA and collagen type III, resulting in ECM deposition and increased apoptosis, hence advancing renal injury development6,9,10. Ginger is a spice widely consumed by people around the world and has been used as an herbal remedy in Asia for over 2,000 years11. Ginger contains a number of pungent compounds, with gingerols being the most abundant of them. Several gingerols with various long side chains are present in ginger, including 6-, 8-, and 10-gingerol, with 6-gingerol (6-G) being the most abundant active compound12. 6-gingerol has been documented to possess anti-inflammatory, antioxidant, and anti-apoptotic characteristics13–15. Whereas a recent study has also shown that 8-G, one of the active compounds in ginger, can mitigate cardiac fibrosis through the PI3K, Akt, mTOR pathways, and oxidative stress16. Zick et al. showed that all of the active compounds in ginger—6-, 8-, and 10-gingerol, as well as 6-shogaol—are effectively absorbed after oral administration in healthy individuals and are well tolerated at dosages up to 2 g. Additionally, they showed that only 6-G was found at doses below 1 gram and that its AUC and Cmax were the highest when compared to 8-, 10-gingerol, and 6-shogaol12. The aim of this study is to analyze the ability of 6-G to alleviate renal interstitial fibrosis via the PI3K, Akt, and mTOR pathways and oxidative stress in UUO rats. Materials and methods Drugs and chemicals Purified 6-G, with a purity of ≥ 98%, was obtained from Actin Chemicals®, Chengdu, China (catalog number: APC-005). The ELISA kit for glutathione peroxidase (GPx; catalog number: MBS744364 was obtained from MyBioSource, San Diego, CA. Antibodies for PI3K (catalog number: 4292), p-PI3K (catalog number: 17366), Akt (catalog number: 9272), p-Akt (catalog number: 9271), mTOR (catalog number: 2972), p-mTOR (catalog number: 2971), and anti-rabbit IgG (catalog number: 7074) were obtained from Cell Signaling Technology (Danvers, MA, USA). Antibody for collagen-III (catalog number: ab7778) was obtained from Abcam, Cambridge, UK. High Pure RNA Isolation Kit (catalog number: 11828665001) and Transcriptor First Strand cDNA Synthesis Kit (catalog number: 043790120001) were purchased from Roche Diagnostics, Mannheim, Germany. The protein molecular weight marker used for Western blotting was purchased from Elabscience (Wuhan, China; catalog number: E-BC-R273) and GenScript (catalog number: M00624-250). Animals The animal study was approved by the Institutional Animal Care and Use Committee of Universitas Indonesia (approval number: KET-1789/UN2.F1/ETIK/PPM.00.02/2023). Eighteen male Sprague-Dawley rats weighing 200 to 220 g (age 8 weeks) used in this study were obtained from the National Agency of Drug and Food Control of Indonesia and were randomly divided into three groups (n = 6 per group). The rats were maintained in controlled conditions with a temperature of 24 –25 °C, humidity levels of 45% − 60%, and a 12-h light/dark cycle. Food and water were provided ad libitum. All the animals were treated ethically in accordance with the protocols established by the Institutional Animal Care and Use Committee and the ARRIVE guidelines. Animals were included if they exhibited no obvious abnormalities and were in good health. The established exclusion criteria comprised failure in the creation of the UUO model or fatality occurring during the study period. Outcome evaluations were performed by an investigator blinded to group allocation. The animal sample size was calculated as the minimum required to reach statistical significance according to the 3Rs (replacement, reduction, and refinement) rules. Induction of unilateral ureteral obstruction Male Sprague Dawley rats were selected for this study to avoid the presence of female reproductive organs, which could complicate the surgical procedure and to minimize physiological variability associated with the estrous cycle, and the UUO model was chosen as a well-established and reproducible method to mimic the pathogenesis of human obstructive nephropathy. Rats underwent either left UUO or sham surgery. Under ketamine and xylazine anesthesia (100 mg/kg and 2 mg/kg, respectively), a 2-cm midline incision was made, and the left ureter was exposed and, in the UUO animals, ligated with 4 − 0 silk suture in the proximal and distal parts of the ureter. The incision was closed in two layers with 4 − 0 silk and staples. Rats in the control group underwent the same surgical procedure; however, the left ureter was just exposed and not ligated. Before the UUO procedure, all rats were randomly assigned using a basic manual randomization technique in order to reduce selection bias to the sham group (n = 6), UUO group (n = 6), and UUO + 6-G group (n = 6). Rats in the UUO + 6-G group were given 6-G through a gastrogavage at a daily dose of 200 mg/kg beginning the first day after surgery and continuing until the groups were euthanized on day 14 after UUO surgery. The 6-G dose was obtained from our previous study (13). 6-G was dissolved in 1.5 mL/kg of corn oil (Mazola Ltd., Indonesia) and given once daily with a maximum volume of administration of 0.4 mL/100 g body weight. The rats were euthanized on day 14 following the UUO procedure using a lethal dose of ketamine and xylazine—three times the anesthetic dose, specifically 300 mg/kg BW and 6 mg/kg BW—after which the left kidney was excised, weighed, and stored in a -80 °C freezer for subsequent analysis. Measurement of malondialdehyde levels Malondialdehyde (MDA; nmol/mg wet tissue) levels were determined based on the thiobarbituric acid reactive substances (TBARS) assay using spectrophotometry. Briefly, left kidney samples were homogenized in cold phosphate-buffered saline (PBS). An aliquot of the homogenate was mixed with an equal volume of thiobarbituric acid (TBA) reagent (Merck, Darmstadt, Germany, Cat. No. 1.08180.0025) consisting of 0.375% TBA, 15% trichloroacetic acid (TCA) (Merck, Darmstadt, Germany, Cat. No. 1.00807.0250), and 0.25 N hydrochloric acid (HCl). The mixture was incubated in a water bath at 95 °C for 30 min to allow the formation of the MDA-TBA adduct. After incubation, the samples were cooled to room temperature and centrifuged at 3000 rpm for 10 min to remove precipitated proteins. The absorbance of the supernatant was measured at 532 nm using a UV-Vis spectrophotometer (PerkinElmer Lambda 25 UV/Vis Spectrometer). MDA concentration was calculated based on a standard curve prepared using 1,1,3,3-tetramethoxypropane (Sigma, Darmstadt, Germany, Cat. No. T-1642) and expressed as nmol MDA per milligram of tissue. Measurement of antioxidant enzyme level The level of glutathione peroxidase (GPx) was determined using a specific ELISA kit according to the manufacturer’s protocols. Briefly, left kidney tissue homogenate samples were prepared and centrifuged to remove debris. Standards and samples were added in duplicate to pre-coated microplate wells, followed by incubation with GPx-horseradish peroxidase conjugate. After washing, substrate solutions were added, and the reaction was stopped with an acidic stop solution. Absorbance was measured at 450 nm using a microplate reader (Bio-Rad iMark MicroPlate Absorbance Reader). GPx concentrations were calculated by interpolation from the standard curve. All samples were analyzed in duplicate, and the results are expressed as ng/mL. Western blot analysis The residual left kidney specimens were sonicated and resuspended in 0.5 mL of RIPA lysis buffer (Sigma-Aldrich, Darmstadt, Germany, Cat. No. R0278). Protein concentrations were determined using a BCA protein assay kit (Sigma-Aldrich, Darmstadt, Germany, Cat. No. BCA1-1KT), and 80 µg of total protein was loaded into each well, separated through SDS-PAGE (5–10% gel), and electrotransferred onto polyvinylidene difluoride membranes. The membranes were incubated overnight at 4 °C with primary antibodies against PI3K (1:1000), p-PI3K (1:500), Akt (1:1000), p-Akt (1:500), mTOR (1:1000), and p-mTOR (1:500), followed by hybridization with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. The protein bands were detected using an ECL advanced system (Sigma-Aldrich, Darmstadt, Germany, Cat. No. GERPN2235) and quantified using ImageJ software (ver. 1.53t, NIH, USA)17. Quantitative reverse transcription real-time PCR Total RNA was isolated from the left kidney tissue utilizing the High Pure RNA Isolation kit in accordance with the manufacturer’s instructions. RNA concentration and purity were evaluated using a Nanodrop 2000 spectrophotometer (Thermo Fisher Scientific) at a wavelength of 260 nm, followed by complementary DNA synthesis utilizing 1 µg of RNA and the Transcriptor First Strand cDNA Synthesis kit in accordance with the manufacturer’s instructions. The expression of α-SMA and TGF-β genes (Table 1) was assessed via quantitative real-time PCR (qRT-PCR) utilizing the LightCycler® 480 Instrument (Roche Applied Science) in conjunction with FastStart Essential DNA Green Master Mix (Roche Life Science). All reactions were conducted uniformly: 95 °C for 10 s, followed by 45 cycles of 95 °C for 15 s and 60 °C for 1 min, with all values normalized to the level of β-actin and calculated using the 2− ΔΔCt method18. Table 1Primer sequence.GenePrimerProduct size (bp)α-SMAForward: CCTCTTCCAGCCATCTTTCATReverse: CGAGAGGACGTTGTTAGCATAG2122TGF-β1Forward: GCAACAATTCCTGGCGTTACReverse: GTATTCCGTCTCCTTGGTTCAG2022 Primer sequence. Forward: CCTCTTCCAGCCATCTTTCAT Reverse: CGAGAGGACGTTGTTAGCATAG 21 22 Forward: GCAACAATTCCTGGCGTTAC Reverse: GTATTCCGTCTCCTTGGTTCAG 20 22 Renal pathological analysis A portion of the excised left kidney, preserved in 10% neutral buffered formalin, was embedded in paraffin, sectioned to a thickness of 4 μm, processed, and stained using hematoxylin-eosin (HE) and Masson’s trichrome staining. The extent of tubular dilation was assessed through HE staining in 10 random fields from 4 experiments, and the index score was calculated accordingly: grade 0, no tubular injury; grade 1, < 10% of tubules injured; grade 2, 10–25% of tubules injured; grade 3, > 25% of tubules injured; and grade 4, severe damage with distinct tubular dilation, sloughing, and denudation. The extent of tubulointerstitial fibrosis was assessed in 10 random fields from 4 experiments within Masson’s trichrome-stained sections. The degree of fibrotic area was assessed semi-quantitatively on a scale from 0 to 4: 0, no fibrosis; 1, < 10%; 2, 10–25%; 3, 26–50%; and 4, > 50% of the tubulointerstitial area affected. ImageJ analysis was conducted on the positive regions of tubular dilation and tubulointerstitial fibrosis, with results presented as a percentage of the affected area19. Histopathological scoring was performed separately by two blinded pathologists using a standardized semi-quantitative scale, without prior knowledge of the sample grouping. Immunohistochemistry for type III collagen Immunohistochemical (IHC) staining was performed on formalin-fixed, paraffin-embedded slices of left kidney tissue sections. Following deparaffinization and hydration, the slides were rinsed in Tris-buffered saline (TBS; 10 mM/L Tris-HCl, 0.85% NaCl, pH 7.2). Endogenous peroxidase activity was inhibited by incubating the slides in 3% H₂O₂ in methanol for 30 min at room temperature. After overnight incubation at 4 °C with the primary antibody, rabbit polyclonal anti-collagen III diluted 1:50, the slides were washed with TBS, followed by the application of HRP-conjugated rabbit anti-goat secondary antibody, which was incubated at room temperature for 45 min. The slides were washed in TBS three times for 5 min each and incubated with diaminobenzidine tetrahydrochloride as the substrate for 10 min, followed by counterstaining with Mayer’s hematoxylin for 2 min. A negative control without primary antibody was incorporated into the experiment to confirm antibody specificity. A semi-quantitative examination of type III collagen was conducted by counting the tubular structures exhibiting strong, moderate, and weak expression levels. For each specimen, ten randomly chosen, non-overlapping regions of the renal cortex were analyzed using a light microscope at 200 X magnification. The categorization of strong, moderate, and weak expression was determined by the visual intensity of IHC staining observed under light microscopy. Tubular structures exhibiting dark brown and diffuse staining were classified as strong expression, those with intermediate staining intensity as moderate expression, and those with faint or light staining as weak expression. This method constitutes a semi-quantitative histopathological evaluation since it approximates relative protein expression through staining intensity and distribution instead of absolute measurement. Statistical analysis All data were expressed as mean ± standard deviation (SD) values. Statistical analysis was performed using SPSS 23.0 software (SPSS Inc., Chicago, IL, USA). Multiple-group comparisons were made using one-way analysis of variance followed by Tukey’s multiple comparison post-test. A p-value of < 0.05 was considered statistically significant. Results 6-Gingerol modulated body weight, kidney weight, and the ratio of kidney weight to body weight On day 14 post-UUO, the body weight of rats in the UUO group decreased; however, kidney weight significantly escalated compared to the sham group, leading to an enhanced ratio of kidney weight to body weight. The administration of 6-G significantly increased body weight relative to the UUO group, and it also significantly decreased kidney weight and the ratio of kidney weight to body weight as compared to the UUO group (Table 2). Table 2Biochemical parameters assessed among groups at the end of the study.ParametersSham (n = 6)UUO (n = 6)UUO + 6-G (n = 6)Body weight (BW) (g)419.6 ± 25.6368.4 ± 38.2*425.2 ± 23.7#Kidney weight (KW) (g)1.3 ± 0.12.1 ± 0.2**1.8 ± 0.2**KW/BW ratio0.3 ± 0.030.6 ± 0.05**0.4 ± 0.02**,##Urine Creatinine (mg/dL)133.3 ± 11.1140 ± 26.7111 ± 26Plasma Creatinine (mg/dL)0.6 ± 0.11.13 ± 0.2*0.8 ± 0.2#Urinary Protein (mg/mL)2.6 ± 0.56.4 ± 1.3**3.3 ± 1.6##Blood urea nitrogen (mg/dL)858.4 ± 691471.9 ± 330**1255.4 ± 118#Urine volume 24 h (mL)6 ± 1.94.9 ± 2.55.4 ± 1.3Creatinine clearance (mL/min)0.96 ± 0.30.44 ± 0.2*0.9 ± 0.3#Malondialdehyde levels (nmol/mg protein)6.5 ± 0.511.1 ± 2.7*9.3 ± 0.9#Glutathione peroxidase (ng/mg total protein)0.3 ± 0.010.1 ± 0.02*0.2 ± 0.03#*p < 0.05 vs. Sham; **p < 0.01 vs. Sham; #p < 0.05 vs. UUO. Biochemical parameters assessed among groups at the end of the study. *p < 0.05 vs. Sham; **p < 0.01 vs. Sham; #p < 0.05 vs. UUO. 6-gingerol modulated biochemical parameters and oxidant/antioxidant balance In comparison to the sham group, rats in the UUO group had elevated levels of urine creatinine, plasma creatinine, urinary protein, and blood urea nitrogen, whereas 24-hour urinary volume and creatinine clearance were decreased in the UUO group relative to the sham group. The administration of 6-G at a dosage of 200 mg/kg/day for 14 days enhanced these parameters towards normal levels (Table 2). The formation of MDA is an early indicator of the induction of oxidative stress. In this study, we found that the left kidney of UUO rats showed increased MDA levels in comparison to rats in the sham group, whereas the antioxidant enzyme GPx decreased in the left kidney of UUO rats compared to sham rats. This oxidant/antioxidant imbalance was significantly improved by 6-G treatment (Table 2). 6-Gingerol decreased the phosphorylation of PI3K/Akt/mTOR and its consequences in UUO kidney Gross examination of the kidneys 14 days after UUO indicated kidney enlargement, and 6-G treatment reduced the enlargement of the obstructed kidney (Fig. 1A). The mRNA expression levels of α-SMA and TGF-β1 were elevated in the left kidney of the UUO rats compared to sham rats (Fig. 1B and C). 6-G treatment decreased expression levels of α-SMA and TGF-β1 mRNA in comparison to UUO rats. 6-gingerol administration improved the macroscopic appearance and alleviated α-smooth muscle actin (α-SMA) and transforming growth factor-β (TGF-β) in the kidneys of unilateral ureteral obstruction (UUO) rats. (A) Representative photographs of gross findings. (B) The mRNA levels of α-SMA and (C) the mRNA levels of TGF-β in the kidneys of sham and UUO rats. All values are expressed as the mean ±SD; n = 6; **p < 0.01 vs. sham and ##p < 0.01 vs. UUO. The activation of the PI3K/Akt/mTOR pathway regulates collagen formation and other extracellular matrix constituents, leading to tissue scarring. This analysis revealed heightened phosphorylation of PI3K/Akt/mTOR in the left kidney of UUO rats compared to the left kidney of sham rats (Fig. 2A-D). 6-gingerol inhibited the PI3K/Akt/mTOR pathway in unilateral ureteral obstruction (UUO) rats. (A) Expression of protein involved in the renal PI3K/Akt/mTOR pathway determined via Western blot analysis. (B-D) Quantitative analysis of relative expression of these proteins (n = 6 per group). All values are expressed as the mean ± SD; *p < 0.05 vs. sham and #p < 0.05 vs. UUO. In comparison to the sham group, the left kidney of the UUO group exhibits tubule dilation as evidenced by HE staining (Fig. 3A-B), renal interstitial fibrosis indicated by Masson’s trichrome staining (Fig. 3D-E), and elevated collagen-III expression demonstrated through immunohistochemistry staining (Fig. 3G-H). The administration of 6-G significantly attenuated tubular dilation, renal interstitial fibrosis, and collagen-III expression generated by UUO (Fig. 3C, F, I and J-L). 6-gingerol attenuated tubulointerstitial injury in unilateral ureteral obstruction (UUO) rat kidney. (A-C) Representative photomicrographs of hematoxylin eosin (HE) staining of kidney section from each group (n = 6 per group). (D-F) Representative photomicrographs of Masson’s trichrome staining of kidney section from each group (n = 6 per group). (G-I) Representative photomicrographs of collagen III immunohistochemistry staining of kidney section from each group (n = 6 per group). Magnification, X200; scale bar, 50 μm; black arrows indicate tubular dilation. (J) Quantitative analysis of tubular dilation area. (K) Quantitative analysis of fibrotic positive area. (L) Quantitative analysis of collagen III positive area. All values are expressed as the mean ± SD; n = 6; **p < 0.01 vs. sham and ##p < 0.01 vs. UUO. Discussion This study demonstrated that the UUO technique induced renal interstitial fibrosis within 14 days, corroborating prior research findings, and treatment with 6-G, an antioxidant, significantly attenuated the UUO-induced renal interstitial fibrosis in rats. It was previously demonstrated that UUO can interfere with the activation of antioxidant enzymes, increase renin-angiotensin-aldosterone system activity, and cause mitochondrial dysfunction, resulting in increased oxidative stress20,21. Furthermore, the suppression of antioxidant enzyme activity due to UUO leads to the progression of renal injury in obstructive nephropathy22. Keivanpour et al. have reported that 6-G could protect both heart and liver organs through its antioxidant and anti-inflammatory effects in septic rats23. We also previously had shown that 6-G decreases NADPH oxidase enzymes and thereby protects against metabolic syndrome-induced kidney injury13. This work aims to illustrate the advantageous effects of 6-G on oxidative stress in renal interstitial fibrosis generated by UUO. The UUO model is a well-established model for hydronephrosis and renal fibrosis, with a pathophysiology similar to that seen in humans with obstructive nephropathy24. The responses that occur following prolonged obstruction due to UUO include interstitial inflammation and oxidative stress, which peak on days 2–3, tubular dilation and atrophy; and tubulointerstitial fibrosis, which becomes apparent starting on day 7 and finally progresses to chronic kidney disease (CKD)4. Various pharmacotherapies have been tried to prevent the progression of obstructive nephropathy to CKD, one of which involves the use of antioxidants25. It has been reported that ginger extract, with its active compounds, namely 6-, 8-, 10-G and 6-shogaol, possesses strong antioxidant activity12. Pharmacokinetic studies of 6-, 8-, and 10-G and 6-shogaol in healthy individuals showed that the AUC and Cmax of 6-G were the highest compared to other active compounds in ginger, and ginger administration at doses up to 2,000 mg per day was found to be well tolerated12. Based on pharmacokinetic data, we chose to investigate the efficacy of 6-G in treating renal interstitial fibrosis in a UUO model. Our study showed that 6-G at a dose of 200 mg/kg/day for 14 days has the ability to reduce oxidative stress – by decreasing MDA levels and increasing GPx levels – and to improve renal interstitial fibrosis. Subsequent to UUO, the imbalance between oxidant and antioxidant enzymes leads to an increased release of oxidation-related proteins and the activation of the PI3K/Akt/mTOR signaling pathway26. The PI3K/Akt/mTOR signaling pathway regulates oxidative stress, which is subsequently influenced by this pathway. It affects the expression of antioxidant enzymes and promotes the upregulation of epithelial-mesenchymal transition genes, such as ⍺-SMA and collagen type III, thereby promoting tissue fibrosis through enhanced extracellular matrix (ECM) deposition6,10. In fact, renal interstitial fibroblasts and myofibroblasts are responsible for excessive ECM production in fibrotic kidneys. The more severe the fibrosis, the higher the myofibroblast count, which is generally expressed by increased α-SMA expression27–29. Previous studies have demonstrated an increase in phosphorylation of the PI3K/Akt/mTOR signaling pathways in obstructed rat kidneys, correlating with the development of tubulointerstitial fibrosis of the kidney9,26,30,31. In the present study we demonstrated that 6-G can improve renal fibrosis in obstructive nephropathy by reducing the phosphorylation of PI3K/Akt/mTOR pathways and oxidative stress. Our study also proves that 6-G can reduce the expression of type III collagen and the expression of α-SMA and TGF-β1 genes in obstructed kidneys, resulting in a reduction in the degree of fibrosis and improvement in kidney structure. In the UUO model, the constant urine flow induces an increase in hydrostatic pressure, which initially dilates the collecting ducts, and subsequently the increase in proximal tubule pressure results in two consequences, namely a reduction in the glomerular filtration rate and mechanical injury to tubular epithelial cells due to stretching32. In line with previous studies, in our study, rats in the UUO group showed a decrease in 24-hour urine volume and an increase in plasma and urine creatinine, BUN, and protein in urine, accompanied by a decrease in creatinine clearance. This indicates that renal function impairment occurred in rats in the UUO group after 14 days of ureter ligation due to renal hypertrophy (Fig. 1A). It has been known that renal hypertrophy may contribute to podocyte injury, proteinuria, and progressive loss of renal function33. The current study demonstrated that 6-G administration enhanced renal function by elevating creatinine clearance to near-normal levels and decreasing proteinuria in obstructed kidneys. This is probably attributable to 6-G’s ability to mitigate oxidative stress and diminish the phosphorylation of PI3K/Akt/mTOR induced by obstructive nephropathy. Antioxidants with SOD-like activity may similarly attenuate renal fibrosis, considering the important contribution of oxidative stress in UUO-induced renal injury34,35. Nevertheless, the renoprotective effects of 6-G are likely mediated not only through antioxidant activity but also through modulation of inflammatory and profibrotic pathways. To the best of our knowledge, this study is among the first to demonstrate that 6-G exerts renoprotective and antifibrotic effects in UUO-induced renal fibrosis through suppression of PI3K/Akt/mTOR pathway activation. This is supported by the reduced phosphorylation of PI3K/Akt/mTOR, along with decreased collagen type III deposition and improved renal histopathological alterations. These findings suggest that 6-G may act not only as an antioxidant compound but also as a modulator of profibrotic intracellular signaling (Fig. 4). Schematic representation describing the possible pathway modulation by 6-gingerol on UUO-induced renal interstitial fibrosis. Conclusions In summary, this study showed that 6-G treatment alleviated the progression of tubulointerstitial renal fibrosis in a UUO model. Inhibition of oxidative stress with an improvement in renal function and renal structure via the PI3K/Akt/mTOR signaling pathway may be one mechanism underlying the renoprotective effects of 6-G. However, we are aware that our study has several limitations, namely that the UUO model represents an acute and accelerated form of renal fibrosis, which may not fully reflect the complex and progressive nature of chronic kidney disease in humans; secondly, the use of a single high dose of 6-gingerol and short treatment duration limit conclusions regarding long-term efficacy and safety; thirdly, the assessment of antifibrotic activity was restricted to selected histological, oxidative stress, and molecular markers; and finally, the lack of a sham treatment for the 6-G group may have resulted in missing additional information about the basal pharmacological effects of 6-G in non-pathological conditions. However, the primary objective of this study was to evaluate the renoprotective effect of 6-G in UUO-induced renal injury. Furthermore, previous studies have shown that administration of 6-G to healthy rats did not result in any significant differences in body weight, kidney weight, BUN, serum creatinine, TBARS levels, or GSH levels compared to healthy control rats36. A broader evaluation of inflammation, immune responses, and functional outcomes would provide a more comprehensive understanding of the protective effects of 6-G. Nevertheless, our findings open avenues for future investigations on the potential role of 6-gingerol as an antifibrotic therapy. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Supplementary Material 6 Acknowledgements We thank Chyswyta and Annisa for helping with technical assistance. Abbreviations Protein Kinase B Alpha Smooth Muscle Actin Chronic kidney disease 6-gingerol Glutathione peroxidase Malondialdehyde mechanistic Target of Rapamycin Phosphatidylinositol 3-kinase Thiobarbituric acid Trichloroacetic acid Thiobarbituric acid substances Transforming growth factor-β1 Unilateral ureteral obstruction Author contributions Conceptualization, V.S.; methodology, V.S.; software, N.A., M.G.M, F.F.H., M.A.R., and A.A.S.; investigation, V.S. and I.B.; resources, V.S. and Ve.Su.; data curation, V.S., N.A., M.G.M., F.F.H., M.A.R., and A.A.S.; writing – original draft preparation, V.S.; writing – review and editing, V.S. and Ve.Su.; visualization, V.S.; supervision, V.S.; project administration, V.S. and I.B.; funding acquisition, V.S. All authors have read and agreed to the published version of the manuscript. Funding This research was funded by Ministry of Education, Culture, Research and Technology of the Republic of Indonesia (PUTIQ1), grant number NKB-314/UN2.RST/HKP.05.00/2024. Data availability All data generated or analyzed during this study are included in this article. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement All data generated or analyzed during this study are included in this article.